Tel Aviv Sourasky Medical Center Successfully Completes Phase 1 Study: 29 out of 30 Moderate-to-Severe COVID-19 Patients Recover in 3 to 5 Days thanks to EXO-CD24
A novel cancer drug known as EXO-CD24 developed and tested at Tel Aviv Sourasky Medical Center (Ichilov Hospital), demonstrates promising […]